October 14th, 2014 – Project CBD, a non-profit organization focusing on cannabidiol research and education, has published a report that questions the integrity of the products and business practices of Medical Marijuana Inc. and its subsidiaries. The report, titled “HEMP OIL HUSTLERS: A Project CBD Special Report on Medical Marijuana Inc., HempMeds and Kannaway”, was published Tuesday by Project CBD.

What began as an investigation into a penny stock umbrella company morphed into a 30-page report involving analytical lab tests, hemp oil production tours, and a “crash course in scientific data regarding toxic solvents, heavy metals, and other contaminants.”

The report sheds some light on the business practices of these three companies, all controlled by the same circle of businessmen, from Kannaway’s multi-level marketing techniques to the “shadowy umbrella corporation known as Medical Marijuana Inc., which has numerous subsidiaries and affiliates.” Both Kannaway and HempMeds (formerly HempMedsPX) are subsidiaries of Medical Marijuana Inc.

The companies claim that their products are legal in all 50 states because oil extracted contains little to no tetrahydrocannabinol (THC), and are derived from an imported industrial hemp paste.

“We believe that industrial hemp is not an optimal source of CBD, but it can be a viable source of CBD if certain hemp cultivars are grown organically in good soil and safe extraction and refinement methods are employed,” writes Project CBD in the forward of the report, adding that CBD production should be derived from “the most prolific natural source” of cannabidiol available — CBD-rich whole plant cannabis containing little THC.

The complete report can be downloaded from Project CBD